Trial Profile
Clinical Trials Insight: 700047160
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2009
Price :
$35
*
At a glance
- Drugs Semapimod (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Cytokine PharmaSciences
- 23 Jul 2009 New trial record.